Pentameric ligand-gated ion channels (pLGICs) belong to a class of ion 28 channels involved in fast synaptic signaling in the central and peripheral nervous 29 systems. Molecules acting as allosteric modulators target binding sites that are remote 30 from the neurotransmitter binding site, but functionally affect coupling of ligand binding 31 to channel opening. Here, we investigated an allosteric binding site in the ion channel 32 vestibule, which has converged from a series of studies on prokaryote and eukaryote 33 channel homologs. We discovered single domain antibodies, called nanobodies, 34
INTRODUCTION 42
In 1965, Monod, Wyman and Changeux postulated the model of allosteric 43 modulation in proteins (Monod, Wyman, and Changeux 1965) . According to this 44 model, proteins exist in two possible conformational states, the tensed (T) or relaxed 45 state (R). The substrate typically has a high affinity for the T state. In multi-subunit 46 proteins, all subunits undergo a concerted transition from the R to the T state upon 47 substrate binding. The equilibrium can be shifted to the R or the T state through a 48 ligand that binds at a site that is different from the substrate binding site, in other words 49 an allosteric site. 50
Changeux subsequently devoted much of his scientific career to the study of 51 allosteric proteins, with specific attention begin paid to the nicotinic acetylcholine 52 receptor (nAChR). This protein is a ligand-gated ion channel (LGIC) and thus in effect 53 has no substrate, but the principle of allosteric modulation is similar in that binding of 54 acetylcholine (ACh) shifts the thermodynamic equilibrium from a closed channel state 55
to an open channel state through binding to a site ~50 Å from the channel gate. The 56 nAChR is a member of a superfamily of pentameric LGICs (pLGICs), which play major 57 roles in fast synaptic transmission in the central and peripheral nervous systems, and 58 are the site of action of many therapeutic drugs. 59
The concept of allosteric modulation is now also more broadly applied to 75 understand the mode of action of certain drugs, called allosteric modulators, which 76 bind at a site that is different from the neurotransmitter binding site, but which can alter 77 energy barriers between multiple conformational states (Bertrand and Gopalakrishnan 78 2007) . For example, in the case of pLGICs, positive allosteric modulators (PAMs) of 79 the nAChR can facilitate a transition from a resting to an activated state, thus 80 enhancing the agonist-evoked response. In contrast, negative allosteric modulators 81 (NAMs) hinder such a transition, thus diminishing the agonist response. From a drug 82 development perspective, PAMs or NAMs are highly attractive as they finely tune 83 receptor activation without affecting the normal fluctuations of neurotransmitter 84 release at the synapse. One of the most extensively described PAMs used in clinic 85 are the benzodiazepines, which act on GABAA receptors and are widely prescribed as 86 hypnotics, anxiolytics, anti-epileptics or muscle relaxants. Important insights into the 87 molecular recognition of these modulators are now revealed by high resolution 88 structural data (Zhu et With the availability of a growing amount of structural data for these receptors, 91 a diverse array of molecules has been revealed, many of which bind at distinct 92 allosteric binding sites, including general anesthetics (Nury et and Gouaux 2011; Althoff et al. 2014) , and many others (Nys et al. 2016) . Detailed 96 investigation of allosteric sites not only brings further knowledge about the receptor 97 functionality but also uncovers novel drug target sites. However, our current 98 understanding of this multi-site mechanism of allosteric modulation in pLGICs is still 99
incomplete. 100
In this study, we used complementary structural and functional approaches to 101 expand our understanding of the molecular mechanism of allosteric modulation in 102 pLGICs. Using the prokaryote ELIC channel as a model, we explored the potential of 103 nanobodies (single chain antibodies) as allosteric modulators. We discovered 104 functionally active nanobodies, which act either as a PAM or NAM on ELIC and 105 determined co-crystal structures to elucidate the nanobody interactions with ELIC. 106
One of the structures reveals an allosteric binding site located near the vestibule of 107 the extracellular ligand-binding domain. Comparison of conservation and divergence 108 in this site in different prokaryotic and eukaryotic receptors suggests a mechanism for 109 achieving subtype-selective allosteric modulation across the receptor superfamily. 110
Using cysteine-scanning mutagenesis and electrophysiological recordings we 111 extrapolate to how the vestibule site can also be targeted for modulation of the human 112 5-HT3A receptor as a proof of principle relevant to other eukaryotic receptors. 113 114 115
RESULTS AND DISCUSSION 116 117
Identification of nanobodies active as allosteric modulators on ELIC 118
In this study, we took advantage of nanobodies, which are high affinity single 119 chain antibodies derived from llamas; they have been widely employed to facilitate 120 structural studies (Manglik, Kobilka, and Steyaert 2017) and also hold potential as 121 therapeutics against many possible targets. A first example, caplacizumab (Cabilivi Ⓡ ), 122 has recently reached the market (Scully et al. 2019 ). Using the prokaryote ion channel 123 ELIC as a model system, we investigated whether nanobodies could be selected with 124 allosteric modulator activity on ligand-gated ion channels. We expressed ELIC 125 channels in Xenopus oocytes and employed automated electrophysiological 126 recordings to characterize a panel of more than 20 different ELIC nanobodies. While 127 none of the nanobodies had any functional effect on ELIC when applied alone, we 128 found that co-application with the agonist GABA evoked a response that broadly falls 129 into 3 categories. One type of nanobodies enhanced the agonist-evoked response, 130 while a 2 nd type of nanobodies diminished the agonist-evoked response and the 3 rd 131 type had little to no effect. From these, we selected several enhancers (PAMs) and 132 inhibitors (NAMs) for a detailed electrophysiological characterization as potential 133 allosteric modulators. In parallel, we conducted X-ray diffraction screening of ELIC 134 plus nanobody co-crystals for structural elucidation. From this selection, we obtained 135 a PAM-active nanobody (PAM-Nb) as well as another NAM-active nanobody (NAM-136 Nb) and determined their structures bound to ELIC by X-ray crystallography. 137
Co-application of the agonist GABA with a range of PAM-Nb concentrations 138 demonstrates that PAM-Nb enhances the agonist response ( Fig. 1a ) with a pEC50-139 value of 5.37±0.03 (EC50: 4.2 µM) and Imax=257±14% (n=8). In contrast, co-application 140 of a range of NAM-Nb concentrations demonstrates that NAM-Nb decreases the 141 agonist response (Fig. 1b ) with a pIC50-value of 6.89±0.03 (IC50: 0.13 µM) and 142 Imax=34±2%% (n=6). Unlike competitive antagonists, which fully inhibit the agonist 143 response at saturating concentrations, the inhibition of NAM-Nb levels off at 70% of 144 the response with GABA alone, consistent with the mode of action of certain NAMs. 145
These results demonstrate that functionally active nanobodies can be developed 146 against the ligand-gated ion channel ELIC. bound to a single pentameric ELIC channel ( Fig. 1c,e ). Each PAM-Nb binds at an 154 intrasubunit site in the ELIC extracellular ligand binding domain. When viewed from 155 the top along the 5-fold symmetry axis the nanobodies extend outward and the 156 structure resembles a 5-bladed propeller (Fig. 1c ). The structure of ELIC in complex 157 with NAM-Nb was determined at a resolution of 3.25Å and is structurally distinct from 158 the complex with PAM-Nb: instead of five Nb molecules bound to the ELIC pentamer, 159 here a single NAM-Nb molecule is bound to the ELIC pentamer ( Fig. 1d ,f). The NAM-160
Nb binds at the channel vestibule entrance and near to the N-terminal a-helix of a 161 single ELIC subunit, and is oriented in such a manner that only a single nanobody 162 molecule can bind at this interface, as the core of the nanobody sterically hinders 163 access to the 4 other sites ( Fig. 1d, 
f). 164
A more detailed analysis of the interaction interface between both nanobodies and 165 ELIC reveals remarkable features (Fig. 2) . The PAM-Nb binds to the extracellular 166 ligand-binding domain and forms extensive interactions through the complementarity 167 determining region CDR1 (residues S25-I33) of the nanobody (Fig. 2a ). The tip of the 168 finger of this loop region wedges in between the ELIC b8-and b9-strand, forming a 169 complex with fragment molecule CU2017, pdb code 5oui) ( Fig. 2a ). In other words, 173
the PAM-Nb binds to a site in ELIC that corresponds to a functionally important 174 allosteric site in the human a7 nAChR, consistent with its function as an allosteric 175
modulator. 176
The mode of interaction of the NAM-Nb with ELIC is distinct from the PAM-Nb 177 ( Fig. 2b) . The interaction interface is remarkable in that none of the CDR1-, CDR2-or 178 CDR3-regions interact with ELIC. Instead, it is the region P104-L110 of the NAM-Nb 179 that forms an a-helix, and which corresponds to a region that has no defined 180 secondary structure in most other nanobody structures. This a-helical region interacts 181 with the a'1-helix in ELIC (N60-N69) and forms the outer rim of an allosteric binding suggesting that the channels are in non-conducting conformations ( Fig. 2c,d ). This 200 closed state is structurally distinct from the putative desensitized state of the a4b2 201 nAChR, whose primary gate lies at the cytoplasmic end at the -1ʹ position 3 . Further In certain structures, we observe that the stretch of amino acids between the 218 b4-and b5-strands resembles the shape of the Greek letter W, for example in the a4 219 Fig. 3b ). Importantly, in both of these 227 conformations access to the vestibule site is occluded. In the W-in conformation, the 228 tip of the W loop prevents access to the vestibule site of its own a4 nAChR-subunit 229 ( Fig. 3a,d) , whereas in the W-out conformation vestibule access is prevented by the 230 tip of the W-out loop of its neighboring a1 GlyR (-) subunit (Fig. 3b,e ). In addition to 231 the tip (not conserved in GluCl). We also observe that in all these cases the W loop is 246 preceded by a stretch of amino acids that forms an additional b-sheet, which we call 247 the b4'-sheet, as it also follows the b4-sheet. The b4'-sheet contains a well conserved 248 start Lys residue, which is present in GlyRs, GABAARs and GluCl. The sequence 249 conservation in these 2 regions suggests an important functional role. In contrast with 250 anionic receptors, we observe that certain cationic receptors can adopt either the W- as residues deeper into the vestibule site, N147, K149 and L151 on the b6-strand and 293 Y86 on the b2-strand (Fig. 4b ). It is interesting to note that N147, K149 and L151 are 294 Representative current traces of channel responses to increasing 300 concentrations of serotonin (5-HT) are shown in Fig. 4a for the L151C mutant before 301 and after modification with MTSEA-biotin. The channel responses are drastically 302 increased after cysteine modification, which is caused by a more than 10-fold increase 303 of the maximal current response (Imax) of the concentration-activation curve after 304 MTSEA-biotin modification as well as a shift of the EC50-value to lower concentrations 305 ( Fig. 4a ,c) (pEC50: 4.01 ± 0.03, n=5 (EC50: 98 µM) versus pEC50: 4.96 ± 0.04, n= 7 306 (EC50: 11 µM)), indicating a strong PAM-effect at this position (P < 0.001). Mutants 307 T112C and K149C also showed a significant decrease of the EC50-value after MTSEA-308 biotin, namely 6.7 µM (pEC50: 5.17 ± 0.02, n=4) versus 2.9 µM (pEC50: 5.53 ± 0.02, 309 n=4) for T112C ( Fig. 3d) (P < 0.0001) and 6.2 µM (pEC50: 5.21 ± 0.05, n=7) versus 310 2.1 µM (pEC50: 5.69 ± 0.11, n=7) for K149C ( Fig. 3e) (P < 0.002). Although neither of 311 these mutants displayed an increase of Imax as in the L151C mutant, the leftward shift 312 of the concentration-activation curve is also consistent with a PAM-effect at these 313 positions. No significant differences were observed for current responses before and 314 after MTSEA-biotin for Y86C, F125C and N147C or the negative control, P111C, 315 suggesting modification of these residues does not place the MTSEA-biotin in an 316 appropriate position to act as a modulator, although it is also possible it did not react 317
here. Together, these results demonstrate that allosteric modulation via the vestibule 318 binding site is functionally conserved between ELIC and 5-HT3A receptors. The 319 evolutionary distance between these receptors, combined with previous work, 320
suggests that this mechanism of modulation likely also extends to other pLGIC 321 members, and indeed the functional importance of the vestibule site in channel 322 modulation is now emerging from a wide range of different studies demonstrating 323 EXPERIMENTAL PROCEDURES 347 348
Production of nanobodies against ELIC 349
A llama was immunized with 2 mg in total of purified wild type ELIC protein over 350 a period of 6 weeks using a previously established protocol (Pardon et al. 2014) . After two rounds of selection, periplasmic extracts were made and subjected to ELISA 359 screens, seven different families were confirmed by sequence analysis. All clones 360 were produced and purified as previously described (Pardon et al. 2014) . 361 362
Nanobody expression and purification 363
A series of nanobodies were individually expressed in the periplasm of E. coli 364 strain WK6, which was grown in TB media supplemented with 0.1 mg/ml carbenicillin, 365 0.1% glucose and 2 mM MgCl2 to an absorbance A600~0.7 at 37°C. The culture was 366 induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and incubated in an supplemented with 50 mg/L gentamicin sulfate. One to five days after injection, 392 electrophysiological recordings were performed at room temperature by automated 393 two-electrode voltage clamp with the HiClamp apparatus (Multi Channel Systems). 394
Cells were superfused with standard OR2 solution containing 82.5 mM NaCl, 2.5 mM 395
KCl, 1.8 mM CaCl2, 1 mM MgCl2 and 5 mM HEPES buffered at pH 7.4. Cells were 396 held at a fixed potential of -80 mV throughout the experiment. Agonist-evoked current 397 responses were obtained by perfusing oocytes with a range of GABA concentrations 398 in OR2 solution. Different nanobodies diluted into OR2 solution were tested at a range 399 of concentrations by pre-incubation with nanobody alone and followed by a co-400 application of nanobody with 5 mM GABA. Data acquired with the HiClamp were 401 analyzed using the manufacturer's software (Multi Channel Systems). Concentration-402 activation curves were fitted with the empirical Hill equation as previously described 403 (Spurny et al. 2012) . 404
ELIC purification and crystallization of ELIC-nanobody complexes 405
Purified ELIC protein was produced as previously described, but with minor 406 modifications (Spurny et al. 2012 ). In brief, the ELIC expression plasmid was 407 transformed into the C43 E. coli strain and cells were grown in LB medium. Protein Crystals were harvested after adding cryo-protectant containing mother liquor 427 gradually supplemented with up to 25% glycerol in 5% increments. Crystals were then 428 plunged into liquid nitrogen and stored in a dewar for transport to the synchrotron. 429 430
Structure determination of ELIC-nanobody complexes 431
Diffraction data for the ELIC+PAM-Nb structure were collected at the PROXIMA 432 1 beamline of the SOLEIL synchrotron (Gif-sur-Yvette, France). Diffraction data for the 433 ELIC+NAM-Nb structure were collected at the X06A beamline of the Swiss Light For the ELIC+PAM-Nb structure, the asymmetric unit contains one ELIC pentamer 438 with 5 nanobodies bound (one to each subunit). For the ELIC+NAM-Nb structure, the 439 asymmetric unit contains 2 ELIC pentamers with 1 nanobody bound to each pentamer. 440
The electron density for one of these nanobody molecules is not well defined, 441
suggesting partial occupancy at this pentamer, and therefore the atom occupancies 442 for this nanobody were manually set to 40% during structure refinement. The data set 443 for the ELIC+NAM-Nb was anisotropic with data extending to ~3.15 Å in the best 444 direction and ~3.5 Å in the worst. To correct for anisotropy the unmerged reflections 445 from XDS where uploaded to the STARANISO server (Paciorek et al. 2018) and 446 automatically processed using CC1/2 > 30 and I/s > 2 as resolution cut-off criteria. 447
The merged and scaled data set from this procedure extends to a resolution of 3.25 Å 448 and the statistics produced by the STARANSIO server are shown in the 449 crystallographic table (supplementary Table 1 
Cysteine-scanning mutagenesis and voltage-clamp recordings of 5-HT3AR 459
Stage V-VI Xenopus oocytes were purchased from Ecocyte (Germany) and 460 stored in ND-96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, 461 pH 7.5) containing 2.5 mM sodium pyruvate, 50 mM gentamicin and 0.7 mM 462 theophylline. cDNA encoding human 5-HT3AR was cloned into the pGEM-HE 463 expression plasmid (Liman, Tytgat, and Hess 1992) . Mutants were engineered using 464 the QuikChange mutagenesis kit (Agilent) and confirmed by sequencing. cRNA was 465 in vitro transcribed from linearized pGEM-HE cDNA template using the mMessage 466 mMachine T7 Transcription kit (ThermoFisher). Oocytes were injected with 50 nl of 467 ~400 ng/µl cRNA, and currents were recorded 18-48 hours post-injection. 5-HT3AR 468 current recordings were obtained using a Roboocyte voltage-clamp system (Multi 469
Channel systems) at a constant voltage clamp of -60 mV. Oocytes were perfused with 470 ND-96 with no added calcium, and 5-HT (creatinine sulphate complex, Sigma) was 471 diluted in this media for obtaining concentration-response curves. MTSEA-biotin 472 (Biotium) was diluted immediately prior to application into calcium-free ND-96 solution 473 at a concentration of 2 mM from a stock solution of 500 mM in DMSO. Analysis and 474 curve fitting was performed using Prism v4.03 (GraphPad Software). Concentration-475 response data for each oocyte were normalized to the maximum current for that 476 oocyte. 477
478
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484
TRANSPARENT REPORTING STATEMENTS 485
All Xenopus electrophysiology experiments were repeated 4-8 times. The 486 number of "n" is mentioned in the relevant sections of the main text. We define each 487 separate oocyte recording as a biological repeat. No data were excluded, unless the 488 oocyte gave no detectable current. All electrophysiology experiments were conducted 489 on automated devices, either the HiClamp or the Roboocyte, so essentially there was 490 no human bias in recording of these data. Data are presented as the mean ± standard 491 error of the mean (SEM) with the raw data points overlaid as a dot plot. Statistical 492 comparison between groups of data was performed using an unpaired two-tailed t test 493 and the significance value P is mentioned in the relevant sections of the manuscript. 494
The X-ray diffraction data sets were collected from single crystals and typically 495 the data set with the highest resolution was used for structural elucidation. Equivalent 496 reflection data were recorded multiple times in agreement with the rotational symmetry 497 of the crystal packing. The relevant data multiplicity value for each data set is 498 mentioned in the crystallographic table (supplementary info). All aspects of X-ray data 499 collection, integration, scaling and merging were fully automated so human bias was 500 excluded. No data were excluded. 501 502 503 504
DATA AVAILABILITY 505
Atomic coordinates and structure factors have been deposited with the Protein 506
Data Bank under accession numbers 6SSI for the ELIC+PAM-Nb structure and 6SSP 507 for the ELIC+NAM-Nb structure. The raw X-ray diffraction images for both data sets 508 have been deposited on datadryad.org under accession number 509 doi:10.5061/dryad.pv4097s. A source file is submitted with the data plotted in Figure  510 1a-b, Figure 2c and Figure 4c 
